double-blind vehicle-controlled study masoprocol cream treatment actinic keratoses head neck double-blind vehicle-controlled multicenter study efficacy safety new topical antineoplastic agent masoprocol treatment actinic keratoses head neck patients topical masoprocol day days mean decrease actinic keratoses median percent reduction baseline actinic keratosis count follow-up visit Comparable numbers vehicle-treated group actinic keratoses median percent reduction Irritation erythema flaking topical masoprocol-treated patients vehicle clinical response Topical masoprocol useful treatment actinic keratoses 